etoposide has been researched along with Bladder Cancer in 111 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 17 (15.32) | 18.7374 |
1990's | 48 (43.24) | 18.2507 |
2000's | 30 (27.03) | 29.6817 |
2010's | 13 (11.71) | 24.3611 |
2020's | 3 (2.70) | 2.80 |
Authors | Studies |
---|---|
Benites, J; Ibacache, A; Rodriguez, JA; Theoduloz, C; Valderrama, JA | 1 |
Ando, T; Hanai, K; Kamitani, R; Kashizaki, F; Mizuno, R; Sekido, Y; Tanaka, A | 1 |
Fuchigami, Y; Iguchi, R; Magaribuchi, T; Naito, H; Ota, H; Shibasaki, N; Terai, A; Tsuruta, M; Yamaguchi, T | 1 |
Chumbalkar, V; Howe, AS; Kogan, BA; Lian, F; Nazeer, T; Pearce, J; Ribbons, L | 1 |
Hashizume, A; Jikuya, R; Kawai, M; Kishida, T; Mizuno, N; Muraoka, K; Tatenuma, T; Umemoto, S; Washimi, K; Yasui, M | 1 |
Bocchia, M; Cencini, E; Fabbri, A; Gentili, F; Mazzei, MA; Schiattone, L | 1 |
Bryant, CM; Dang, LH; Gilbert, SM; Morris, CG; Stechmiller, BK; Zlotecki, RA | 1 |
Arai, H; Honda, M; Kobayashi, Y; Ueda, N; Yoshida, K | 1 |
Appaji, L; Padma, M; Ramanathan, S; Suma, MN; Suma, TL | 1 |
Clozel, T; Elemento, O; Erdem, Z; Hassler, MR; Krzywinski, M; Robinson, BD; Shariat, SF; Xylinas, E; Zhuang, D | 1 |
Heidegger, I; Horninger, W; Pichler, R; Schäfer, G; Tulchiner, G | 1 |
Fujii, Y; Fukui, I; Kawakami, S; Komai, Y; Okubo, Y; Yamamoto, S; Yonese, J | 1 |
Dinney, CP; Grossman, HB; Kamat, AM; Millikan, RE; Qiao, W; Siefker-Radtke, AO; Thall, PF; Williams, DL | 1 |
Kawashima, A; Miyoshi, S; Nin, M; Nishimura, K; Ujike, T | 1 |
He, DW; Li, XL; Lin, T; Liu, JH; Liu, X; Wei, GH; Zhang, DY | 1 |
Araki, M; Hasegawa, H; Ikura, Y; Itoh, M; Kuzushita, N; Mita, E; Nakazuru, S; Ohta, M; Suemura, S; Toyama, T; Yoshio, T; Yoshioka, C | 1 |
Cassier, P; Chapet, O; Chekrine, T; De Bari, B; Kulisa, M; Mornex, F | 1 |
Fukui, I; Kitsukawa, S; Komai, Y; Kubo, Y; Okubo, Y; Saito, K; Urakami, S; Yamamoto, S; Yasuda, Y; Yonese, J | 1 |
Aiello, E; Colarossi, C; Costanzo, R; Giuffrida, D; Martinetti, D; Memeo, L; Pino, P | 1 |
Chen, WJ; Chuang, JH; Huang, HY; Jeng, YM; Ko, SF; Sung, MT | 1 |
Fukui, I; Ishii, N; Maezawa, T; Tsukamoto, T; Yonese, J | 1 |
Berry, LR; Chan, AK; Paredes, N; Xu, L | 1 |
Austin, RC; Baumeister, P; Kaufman, RJ; Lee, AS; Mao, C; Reddy, RK | 1 |
al Rabi, N; Artibani, W; Dalpiaz, O; Ficarra, V; Galfano, A; Martignoni, G | 1 |
Bor, MV; Nexø, E; Sørensen, BS; Tørring, N | 1 |
Cook, A; Izawa, JI; Mack, DP; Moussa, M | 1 |
deVere White, RW; Ellison, LM; Gandour-Edwards, R; Goldberg, Z; Karpman, E; Saffarian, A | 1 |
Bex, A; Horenblas, S; Kerst, M; Meinhardt, W; Nieuwenhuijzen, JA; Pos, F; van Boven, H | 1 |
Miyagawa, I; Sejima, T | 1 |
Adachi, S; Fukuhara, S; Hara, T; Mori, N; Tsutahara, K; Yamaguchi, S; Yokoyama, S | 1 |
Fujikawa, N; Hirai, K; Hirokawa, S; Kita, K; Kitami, K; Mikata, K; Sano, H; Ueki, T | 1 |
Kageyama, Y; Kihara, K; Kobayashi, T; Kubo, Y; Yokoyama, M | 1 |
Fujioka, H; Honda, M; Matsumiya, K; Satoh, M; Takada, T; Tujimoto, Y | 1 |
Bode, AM; Choi, BY; Choi, HS; Dong, Z; Ermakova, SP; Kang, BS; Ma, WY; Schuster, TF | 1 |
Kamoto, T; Kawahara, T; Nishiyama, H; Ogawa, O; Yamamoto, S | 1 |
Chang, CC; Lin, PR; Shiau, AL; Shieh, GS; Tzai, TS; Wu, CL; Yo, YT | 1 |
Memon, AA; Munk, M; Nexo, E; Sorensen, BS | 1 |
Kenna, T; Mattarollo, SR; Nicol, AJ; Nieda, M | 1 |
Cobo, ML; Gómez-Román, JJ; Val-Bernal, JF | 1 |
Uchibayashi, T | 1 |
Płuzańska, A; Robak, T | 1 |
Fujita, K; Murayama, T; Sayama, T | 1 |
Blatnik, A; Matheny, RB; Niell, HB; Soloway, MS | 1 |
Oliver, RT; Ponder, BA | 1 |
Seematter, RJ | 1 |
Kitamura, Y; Komatsubara, S; Sakata, Y; Watanabe, M | 2 |
Kawakami, M; Kobayashi, S; Niwakawa, M; Ogawa, A; Okaneya, T; Tsuruta, T | 1 |
Barzan, L; Canzonieri, V; Dal Bo, V; Lo Re, G; Trovò, M; Veronesi, A; Zancanaro, C | 1 |
Chuchkova, M; Damianov, C; Koleva, P; Terziev, T | 1 |
Hirano, A; Hiroi, A; Inagaki, T; Uekado, Y | 1 |
Kobayashi, H; Obata, K | 1 |
Chang, JH; Grossman, HB; Liebert, M; Shinohara, N; Wedemeyer, G | 1 |
Arakawa, S; Gotoh, A; Kamidono, S; Kitazawa, S; Maeda, S; Matsuwari, S; Mizuno, Y | 1 |
Hahn, RG; Hatcher, PA; Richardson, RL; Zincke, H | 1 |
Kondoh, M; Miki, T; Nakamura, N; Nakano, E; Nishimura, K; Okuyama, A; Seguchi, T | 1 |
Cassidy, J; Kaye, SB | 1 |
Igawa, M; Kadena, H; Matsuura, H; Ohkuchi, T; Ueda, M; Usui, T | 1 |
Inagaki, T; Touge, H; Uekado, Y; Watanabe, T | 1 |
Hasegawa, S; Koga, H; Kotoh, S; Kumazawa, J; Kuwano, M; Naito, S; Yokomizo, A | 1 |
Chresta, CM; Hickman, JA; Masters, JR | 1 |
Hashimoto, H; Iuchi, H; Morikawa, M; Numata, A; Tokumitsu, M; Yachiku, S; Yamauchi, K | 1 |
Aikawa, K; Irisawa, C; Ishibashi, K; Ishiwata, H; Koseki, K; Ogihara, M; Shiraiwa, Y | 1 |
Abu Rabia, A; el-Attar, I; el-Said, A; Gaafar, R; Gad el-Mawla, N; Hamza, MR; Khaled, HM; Magrath, I | 1 |
Akaza, H; Kawai, K | 1 |
Bleicher, RJ; Gupta, V; Singh, SV; Xia, H; Zaren, HA | 1 |
Aikawa, K; Ishibashi, K; Koseki, K; Ogihara, M; Shiraiwa, Y; Yamaguchi, O | 1 |
Clark, PI; Parr, NJ; Venkatesh, R | 1 |
Eishi, Y; Fukuda, H; Kanno, J; Kawakami, S; Kihara, K; Morita, T; Nagahama, K; Ohtsuka, Y; Okada, Y; Oshima, H; Saito, K | 1 |
Goessl, C; Heicappell, R; Miller, K; Müller, M; Steiner, U | 1 |
Chen, CL; Horng, YY; Kao, YL; Kuo, JH; Ou, YC; Yang, CR; Yang, CS; Yean, SY | 1 |
Horiuchi, S; Negishi, T; Tsukamoto, T; Urushibara, M | 1 |
Brehmer, B; Jakse, G; Kapp, T; Rohde, D; Valdor, M | 1 |
Hoshino, T; Iwamoto, T; Kuroko, K; Nishida, S; Shirai, C | 1 |
Arriola, EL; Chresta, CM; Lopez, AR | 1 |
Akaza, H; Tsukamoto, S | 1 |
Fujikawa, K; Hoshii, Y; Ishizu, K; Kawamura, H; Konishi, M; Naito, K; Ohmi, C; Shimizu, Y; Takahashi, M; Yamaguchi, S | 1 |
Arai, E; Horii, Y; Iwamura, H | 1 |
Deguchi, T; Kamei, S; Miwa, K; Nishida, Y; Takahashi, Y; Yamada, T | 1 |
Barret, JM; Etiévant, C; Guminski, Y; Hill, BT; Kruczynski, A; Perrin, D; van Hille, B | 1 |
Akinaga, S; Benedict, WF; Ko, K; Mizukami, T; Motoda, H; Shinohara, H; Takahashi, R; Tamaoki, T; Yamaoka, Y; Yazumi, S; Yoshida, T; Yoshikawa, K; Zhou, J | 1 |
Inoue, K; Kasahara, K; Shuin, T | 1 |
Fukui, I; Ishiwata, D; Kim, T; Tohma, T; Tsukamoto, T; Yonese, J; Yoshida, T | 1 |
Cowan, DS; Egorin, MJ; Lee, CM; Tannock, IF; Tunggal, JK | 1 |
Akaza, H; Hattori, K; Kawai, K; Miyanaga, N; Shimazui, T; Tsukamoto, S; Uchida, K | 1 |
Henney, JE; Muggia, FM; Rozencweig, M; Von Hoff, DD | 1 |
Hirano, A; Ohkawa, T; Shinka, T; Uekado, Y | 1 |
Ingargiola, GB; Pavone-Macaluso, M; Serretta, V | 1 |
Akiyama, M; Inoue, Y; Sumiyoshi, Y; Yokota, K | 1 |
Kondo, I; Miura, T; Murai, T; Shimura, H | 1 |
Eiro, I; Kanetsuki, I; Nakajo, M; Onohara, S; Takeshita, T; Uchiyama, N; Yano, T | 1 |
Chresta, CM; Davies, SM; Fry, AM; Harris, AL; Hartley, JA; Hickson, ID; Masters, JR; Walker, MC | 1 |
Colbeck, RA; Crawford, SM; Williams, G | 1 |
Floyd, JW; Lin, CW; Prout, GR | 1 |
Feng, MR; Grossman, HB; Liebert, M; Mancini, WR; Wagner, JG; Wedemeyer, G; Williams, M | 1 |
Akimoto, M; Hattori, T; Nishimura, T; Satoh, M; Terashima, Y | 1 |
Akiyama, M; Sumiyoshi, Y; Yokota, K | 1 |
Akao, T; Hashimura, T; Nakagawa, T; Okumura, K | 1 |
Morikawa, Y; Tanaka, S | 1 |
Miura, K; Tsukada, T; Yuri, Y | 1 |
Musk, SR; Steel, GG | 1 |
Kotake, T; Kuroda, M; Miki, T | 1 |
Davis, MP; Minton, JP; Murthy, MS; Simon, J; Wise, H | 1 |
Iizumi, T; Soma, G; Waku, M; Yazaki, T | 1 |
Itoh, K; Kokado, Y; Kyakuno, M; Sagawa, S; Sakai, H; Shin, T | 1 |
Buckley, NJ; Das, AK; Poulton, SH; Walther, PJ | 1 |
Alexander, RB; Coffey, DS; Isaacs, JT | 1 |
Suzuki, K | 1 |
Birch, R; Einhorn, LH; Greco, FA; Troner, M; Walther, PJ; Williams, SD | 1 |
Oliver, RT | 1 |
Aota, Y; Kinjo, T; Mitsuya, H; Murase, T; Shimoji, T | 1 |
15 review(s) available for etoposide and Bladder Cancer
Article | Year |
---|---|
[Intravesical Recurrence of Small Cell Carcinoma of the Ureter: A Case Report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Humans; Male; Middle Aged; Nephrectomy; Recurrence; Ureteral Neoplasms; Urinary Bladder Neoplasms | 2016 |
[Plasmacytoid urothelial carcinoma of the bladder: a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Diagnostic Imaging; Etoposide; Humans; Lymphatic Metastasis; Male; Methotrexate; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 2009 |
[Case of primary hepatic neuroendocrine carcinoma diagnosed by needle biopsy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carcinoma, Neuroendocrine; Carcinoma, Transitional Cell; Cisplatin; Diagnosis, Differential; Diagnostic Imaging; Etoposide; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasms, Multiple Primary; Urinary Bladder Neoplasms | 2010 |
[Small cell neuroendocrine carcinoma of the bladder: A case report and review of the literature].
Topics: Acute Kidney Injury; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Carcinoma in Situ; Carcinoma, Neuroendocrine; Carcinoma, Transitional Cell; Combined Modality Therapy; Emergencies; Etoposide; Humans; Lymphatic Irradiation; Lymphatic Metastasis; Male; Neoadjuvant Therapy; Neoplasms, Multiple Primary; Prognosis; Prostatic Hyperplasia; Topoisomerase I Inhibitors; Topotecan; Urinary Bladder Neoplasms | 2011 |
Small cell carcinoma of the bladder: a case report and a literature review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cystectomy; Doxorubicin; Etoposide; Fatal Outcome; Humans; Ifosfamide; Life Tables; Liver Neoplasms; Male; Middle Aged; Stevens-Johnson Syndrome; Survival Analysis; Urinary Bladder Neoplasms; Vincristine | 2003 |
Analysis of treatment for small cell cancer of the bladder and report of three cases.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Biomarkers, Tumor; Bone Neoplasms; Carboplatin; Carcinoma, Small Cell; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Cystectomy; Deoxycytidine; Disease Progression; Etoposide; Gemcitabine; Humans; Life Tables; Liver Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasms, Second Primary; Prostatectomy; Retrospective Studies; Treatment Outcome; Urinary Bladder Neoplasms; Urinary Diversion | 2004 |
[The role of etoposide therapy in urogenital cancer].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Female; Humans; Kidney Neoplasms; Male; Prostatic Neoplasms; Urinary Bladder Neoplasms; Vinblastine | 1996 |
[Small cell carcinoma of the urinary bladder: a case report and review of the Japanese literature].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Male; Middle Aged; Urinary Bladder Neoplasms | 1997 |
[Progress in oral anti-cancer drug therapy for urological cancer].
Topics: Administration, Oral; Androgen Antagonists; Antineoplastic Agents, Hormonal; Drug Administration Schedule; Drug Combinations; Estramustine; Etoposide; Female; Flutamide; Humans; Kidney Neoplasms; Male; Prostatic Neoplasms; Tegafur; Uracil; Urinary Bladder Neoplasms | 1999 |
[Combined treatment with CDDP and radiation effective against neuroendocrine carcinoma of the urinary bladder: a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Male; Treatment Outcome; Urinary Bladder Neoplasms | 1999 |
[Small cell neuroendocrine carcinoma of the urinary bladder: a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cystectomy; Etoposide; Humans; Lymphatic Metastasis; Male; Middle Aged; Urinary Bladder Neoplasms | 1999 |
[Chemotherapy and radiotherapy for urological cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Kidney Neoplasms; Male; Methotrexate; Prostatic Neoplasms; Testicular Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Vinblastine | 2002 |
VM 26 and VP 16-213: a comparative analysis.
Topics: Animals; Brain Neoplasms; Drug Evaluation; Etoposide; Humans; Kinetics; Leukemia; Lung Neoplasms; Lymphoma; Neoplasms, Experimental; Podophyllotoxin; Teniposide; Urinary Bladder Neoplasms | 1977 |
The role of epipodophyllotoxin derivatives in bladder cancer.
Topics: Combined Modality Therapy; Etoposide; Humans; Remission Induction; Teniposide; Urinary Bladder Neoplasms | 1992 |
Small cell carcinoma of the urinary bladder: a case of remarkable remission with combined chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Humans; Lymphatic Metastasis; Male; Remission Induction; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 1988 |
9 trial(s) available for etoposide and Bladder Cancer
Article | Year |
---|---|
Phase II clinical trial of neoadjuvant alternating doublet chemotherapy with ifosfamide/doxorubicin and etoposide/cisplatin in small-cell urothelial cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Prospective Studies; Time Factors; Treatment Outcome; Urinary Bladder Neoplasms; Urothelium | 2009 |
[Bladder preservation for locally advanced bladder cancer by transurethral resection, systemic chemotherapy and radiation].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cystectomy; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Radiotherapy Dosage; Urinary Bladder Neoplasms; Vinblastine | 2006 |
[New antineoplastic drugs of the podophyllotoxin derivative group].
Topics: Adult; Child; Clinical Trials as Topic; Etoposide; Female; Humans; Leukemia; Lung Neoplasms; Lymphoma; Neoplasms; Ovarian Neoplasms; Podophyllotoxin; Teniposide; Urinary Bladder Neoplasms | 1983 |
Combined immunochemotherapy (CEP, M-VEP + BCG) in the treatment of invasive bladder tumors.
Topics: Administration, Intravesical; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Cisplatin; Combined Modality Therapy; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Immunotherapy, Active; Lomustine; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Prednimustine; Urinary Bladder Neoplasms; Vinblastine | 1994 |
[Intraarterial chemotherapy for patients with invasive bladder cancer--clinical effects and preliminary results in bladder preservation].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Neoplasm Invasiveness; Urinary Bladder; Urinary Bladder Neoplasms | 1994 |
Results of adjuvant chemotherapy for invasive urothelial cancer with lymph-node metastasis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Kidney Neoplasms; Kidney Pelvis; Longitudinal Studies; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Survival Rate; Ureteral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Vinblastine | 1994 |
Neoadjuvant chemotherapy for invasive bladder carcinoma: disease outcome and bladder preservation and relationship to local tumor response.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Survival Rate; Time Factors; Urinary Bladder Neoplasms; Vinblastine | 1994 |
Combination chemotherapy for advanced bilharzial bladder carcinoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Mesna; Middle Aged; Schistosomiasis; Survival Rate; Treatment Outcome; Urinary Bladder Neoplasms; Vincristine | 1996 |
Results of adjuvant chemotherapy for invasive uroepithelial cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Kidney Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Survival Rate; Ureteral Neoplasms; Urinary Bladder Neoplasms | 1992 |
87 other study(ies) available for etoposide and Bladder Cancer
Article | Year |
---|---|
Studies on quinones. Part 47. Synthesis of novel phenylaminophenanthridinequinones as potential antitumor agents.
Topics: Aniline Compounds; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Fibroblasts; Humans; Inhibitory Concentration 50; Lung Neoplasms; Molecular Structure; Phenanthridines; Quinones; Stomach Neoplasms; Structure-Activity Relationship; Urinary Bladder Neoplasms | 2011 |
Long-term complete response in small cell bladder carcinoma treated with carboplatin, etoposide, and atezolizumab.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Humans; Lung Neoplasms; Male; Urinary Bladder; Urinary Bladder Neoplasms | 2022 |
[A Case of Small Cell Carcinoma of the Bladder].
Topics: Aged; Carcinoma, Small Cell; Cystectomy; Etoposide; Humans; Male; Urinary Bladder Neoplasms | 2020 |
A Case of Ewing Sarcoma of the Bladder Presenting in Early Infancy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hematuria; Humans; Ifosfamide; Infant; Sarcoma, Ewing; Treatment Outcome; Urinary Bladder; Urinary Bladder Neoplasms; Vincristine | 2021 |
[A Case of Long Survival in Aggressively Growing Small Cell Carcinoma of the Bladder Successfully Treated by Combined Chemotherapy of Methotrexate, Etoposide and Cisplatin].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Humans; Magnetic Resonance Imaging; Male; Methotrexate; Time Factors; Urinary Bladder Neoplasms | 2017 |
Durable response after VNCOP-B and rituximab in an elderly patient with high-grade B-cell lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Etoposide; Humans; Lymphoma, B-Cell; Male; Mitoxantrone; Prednisone; Rituximab; Urinary Bladder; Urinary Bladder Neoplasms; Vincristine | 2018 |
Treatment of Small Cell Carcinoma of the Bladder With Chemotherapy and Radiation after Transurethral Resection of a Bladder Tumor.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Transitional Cell; Chemoradiotherapy, Adjuvant; Cisplatin; Cohort Studies; Cystoscopy; Disease-Free Survival; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Complex and Mixed; Organ Sparing Treatments; Retrospective Studies; Urinary Bladder; Urinary Bladder Neoplasms; Vinblastine; Vinorelbine | 2016 |
A Case of Urachal Yolk Sac Tumor With Spontaneous Rupture in a Child.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Carboplatin; Combined Modality Therapy; Consanguinity; Emergencies; Endodermal Sinus Tumor; Etoposide; Hemoperitoneum; Humans; Infant; Laparotomy; Male; Rupture, Spontaneous; Tomography, X-Ray Computed; Urachus; Urinary Bladder Neoplasms | 2017 |
An Epigenomic Approach to Improving Response to Neoadjuvant Cisplatin Chemotherapy in Bladder Cancer.
Topics: Antineoplastic Agents; Azacitidine; Biomarkers, Tumor; Cell Line, Tumor; Cisplatin; Decitabine; Doxorubicin; Drug Resistance, Neoplasm; Epigenomics; Etoposide; Homeodomain Proteins; Humans; Hydroxamic Acids; Methylation; Neoadjuvant Therapy; Promoter Regions, Genetic; Urinary Bladder Neoplasms; Vinblastine; Vorinostat | 2016 |
Long term disease free survival with multimodal therapy in small cell bladder cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cystectomy; Disease-Free Survival; Etoposide; Humans; Lymph Node Excision; Male; Middle Aged; Prostatectomy; Treatment Outcome; Urinary Bladder Neoplasms | 2016 |
Combination chemotherapy of ifosfamide, 5-fluorouracil, etoposide and cisplatin as perioperative treatment in lymph node positive bladder carcinoma patients treated by radical cystectomy.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cystectomy; Etoposide; Female; Fluorouracil; Humans; Ifosfamide; Lymphatic Metastasis; Male; Middle Aged; Survival Rate; Urinary Bladder Neoplasms | 2008 |
A rare case of simultaneous occurrence of Wilms' tumor in the left kidney and the bladder.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Humans; Infant; Kidney Neoplasms; Male; Neoplasms, Multiple Primary; Ultrasonography; Urinary Bladder Neoplasms; Vincristine; Wilms Tumor | 2010 |
Impact of C-reactive protein kinetics on survival of patients with advanced urothelial carcinoma treated by second-line chemotherapy with gemcitabine, etoposide and cisplatin.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; C-Reactive Protein; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Etoposide; Female; Gemcitabine; Humans; Male; Middle Aged; Prognosis; Survival Rate; Urinary Bladder Neoplasms | 2012 |
Large cell neuroendocrine carcinoma (LCNEC) of the urinary bladder: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Etoposide; Fatal Outcome; Female; Humans; Immunohistochemistry; Middle Aged; Neoadjuvant Therapy; Treatment Outcome; Urinary Bladder Neoplasms | 2013 |
Primary yolk sac tumor of the urachus.
Topics: alpha 1-Antitrypsin; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; DNA, Neoplasm; Endodermal Sinus Tumor; Etoposide; Flow Cytometry; Humans; Immunohistochemistry; Infant; Keratins; Male; Nuclear Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; Tomography, X-Ray Computed; Treatment Outcome; Urachus; Urinary Bladder Neoplasms | 2002 |
[Combination chemotherapy with ifosfamide, 5-fuluorouracil, etoposide and cisplatin for advanced urothelial cancer: the treatment results and significance of tumor marker evaluation in response assessment of chemotherapy].
Topics: Aged; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; CA-19-9 Antigen; Carcinoembryonic Antigen; Carcinoma, Transitional Cell; Cisplatin; Etoposide; Evaluation Studies as Topic; Female; Fluorouracil; Humans; Ifosfamide; Male; Middle Aged; Serpins; Urinary Bladder Neoplasms; Urologic Neoplasms | 2002 |
The effects of chemotherapeutic agents on the regulation of thrombin on cell surfaces.
Topics: alpha-Macroglobulins; Antineoplastic Agents; Antithrombins; Cell Membrane; Doxorubicin; Etoposide; Humans; Methotrexate; Prothrombin; Thrombin; Thromboplastin; Thrombosis; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Vincristine | 2003 |
Endoplasmic reticulum chaperone protein GRP78 protects cells from apoptosis induced by topoisomerase inhibitors: role of ATP binding site in suppression of caspase-7 activation.
Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Binding Sites; Camptothecin; Carrier Proteins; Caspase 7; Caspases; Cell Membrane; Cricetinae; Doxorubicin; Endoplasmic Reticulum; Endoplasmic Reticulum Chaperone BiP; Enzyme Precursors; Etoposide; G1 Phase; Gene Expression; Heat-Shock Proteins; Humans; Leukemia; Molecular Chaperones; Protein Structure, Tertiary; Subcellular Fractions; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Transfection; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 2003 |
The DNA damaging agent VP16 induces the expression of a subset of ligands from the EGF system in bladder cancer cells, whereas none of the four EGF receptors are induced.
Topics: Amphiregulin; Antineoplastic Agents, Phytogenic; Betacellulin; Cell Line, Tumor; Cell Membrane; Cycloheximide; Dose-Response Relationship, Drug; EGF Family of Proteins; Epidermal Growth Factor; Epiregulin; ErbB Receptors; Etoposide; Gene Expression Regulation, Neoplastic; Glycoproteins; Humans; Intercellular Signaling Peptides and Proteins; Ligands; Protein Synthesis Inhibitors; RNA, Messenger; Transforming Growth Factor alpha; Urinary Bladder Neoplasms | 2004 |
Metastatic Merkel cell tumor to the prostate and bladder.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Merkel Cell; Combined Modality Therapy; Etoposide; Facial Neoplasms; Fatal Outcome; Humans; Kidney Neoplasms; Liver Neoplasms; Lymphatic Metastasis; Male; Palliative Care; Prostatic Neoplasms; Radiotherapy, Adjuvant; Spinal Neoplasms; Transurethral Resection of Prostate; Urethral Obstruction; Urinary Bladder Neoplasms | 2004 |
Small cell carcinoma of bladder: a single-center prospective study of 25 cases treated in analogy to small cell lung cancer.
Topics: Age Factors; Aged; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Comorbidity; Cyclophosphamide; Cystectomy; Doxorubicin; Etoposide; Feasibility Studies; Female; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Palliative Care; Prognosis; Prospective Studies; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 2005 |
'Successful' chemo- and radiotherapy prior to radical cystectomy does not necessarily correlate with clinical course in small cell carcinoma of the bladder.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cystectomy; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Male; Preoperative Care; Treatment Outcome; Urinary Bladder Neoplasms | 2005 |
[Small cell carcinoma of the urinary bladder: a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Urinary Bladder Neoplasms | 2005 |
[Small cell carcinoma of the bladder: a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Carcinoma, Transitional Cell; Combined Modality Therapy; Cystectomy; Drug Administration Schedule; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms, Multiple Primary; Urinary Bladder Neoplasms; Urinary Diversion | 2005 |
[A case of secondary malignant lymphoma of the urinary bladder].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Mesna; Middle Aged; Mitoxantrone; Prednisone; Urinary Bladder Neoplasms; Vincristine | 2006 |
(-)-Epigallocatechin gallate overcomes resistance to etoposide-induced cell death by targeting the molecular chaperone glucose-regulated protein 78.
Topics: Adenosine Triphosphatases; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Caspase 7; Caspase Inhibitors; Catechin; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Endoplasmic Reticulum Chaperone BiP; Etoposide; Heat-Shock Proteins; Humans; Mice; Molecular Chaperones; Protein Conformation; Urinary Bladder Neoplasms | 2006 |
Protocol consisting of cisplatin, etoposide and irinotecan induced complete pathological remission of primary small cell carcinoma of the bladder.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Etoposide; Humans; Irinotecan; Male; Neoadjuvant Therapy; Remission Induction; Urinary Bladder Neoplasms | 2006 |
Low-dose etoposide enhances telomerase-dependent adenovirus-mediated cytosine deaminase gene therapy through augmentation of adenoviral infection and transgene expression in a syngeneic bladder tumor model.
Topics: Adenoviridae; Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Combined Modality Therapy; Coxsackie and Adenovirus Receptor-Like Membrane Protein; Cytosine Deaminase; Dose-Response Relationship, Drug; Drug Synergism; Etoposide; Flucytosine; Genetic Therapy; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Mice, Inbred C3H; Promoter Regions, Genetic; Receptors, Virus; Telomerase; Transgenes; Up-Regulation; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays | 2006 |
Inhibition of the epidermal growth factor receptor in bladder cancer cells treated with the DNA-damaging drug etoposide markedly increases apoptosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Survival; ErbB Receptors; Etoposide; Gefitinib; Humans; Quinazolines; Treatment Outcome; Urinary Bladder Neoplasms | 2007 |
Chemotherapy and zoledronate sensitize solid tumour cells to Vgamma9Vdelta2 T cell cytotoxicity.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Burkitt Lymphoma; Carcinoma; Cell Line, Tumor; Cisplatin; Colorectal Neoplasms; Concanavalin A; Cytotoxicity, Immunologic; Diphosphonates; Doxorubicin; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; Female; Genes, T-Cell Receptor delta; Genes, T-Cell Receptor gamma; Humans; Imidazoles; Interferon-gamma; Lovastatin; Lung Neoplasms; Male; Membrane Glycoproteins; Neoplasms; Perforin; Pore Forming Cytotoxic Proteins; Prostatic Neoplasms; Receptors, Antigen, T-Cell, gamma-delta; T-Lymphocyte Subsets; Urinary Bladder Neoplasms; Vincristine; Zoledronic Acid | 2007 |
Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma presenting as a bladder neoplasm.
Topics: Anaplastic Lymphoma Kinase; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Transitional Cell; Cisplatin; Cytarabine; Diagnosis, Differential; Disease-Free Survival; Etoposide; Humans; Ki-1 Antigen; Lymphoma, Large-Cell, Anaplastic; Male; Methylprednisolone; Middle Aged; Mucin-1; Protein-Tyrosine Kinases; Receptor Protein-Tyrosine Kinases; Treatment Outcome; Urinary Bladder Neoplasms | 2008 |
[Chemosensitivity in established human bladder carcinoma and HELA cell lines in vitro].
Topics: Antineoplastic Agents; Bleomycin; Carbazilquinone; Carcinoma, Transitional Cell; Cell Division; Cell Line; Cell Survival; Cells, Cultured; Cisplatin; Doxorubicin; Drug Evaluation, Preclinical; Etoposide; HeLa Cells; Humans; Male; Mitomycin; Mitomycins; Nimustine; Nitrosourea Compounds; Thiotepa; Urinary Bladder Neoplasms | 1983 |
[Effect of etoposide for pulmonary metastases from urogenital tract cancer].
Topics: Adenocarcinoma; Administration, Oral; Aged; Carcinoma, Transitional Cell; Etoposide; Humans; Infusions, Parenteral; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin; Prostatic Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms | 1984 |
Systemic chemotherapy of murine bladder cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cell Line; Cisplatin; Disease Models, Animal; Dose-Response Relationship, Drug; Etoposide; FANFT; Female; Methotrexate; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Urinary Bladder Neoplasms | 1984 |
Phase II study of VP 16-213 (etoposide) in metastatic transitional cell urothelial cancer.
Topics: Adult; Aged; Carcinoma, Transitional Cell; Drug Evaluation; Etoposide; Humans; Infusions, Parenteral; Middle Aged; Podophyllotoxin; Urinary Bladder Neoplasms | 1984 |
[Systemic chemotherapy of bladder cancer].
Topics: Aged; Antineoplastic Agents; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; Humans; Middle Aged; Urinary Bladder Neoplasms | 1982 |
[Comparative study on urinary parameters reflecting renal damage during chemotherapy for urological cancer].
Topics: Acetylglucosaminidase; Adolescent; Adult; Aged; Aminopeptidases; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD13 Antigens; Cisplatin; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Etoposide; Humans; Ifosfamide; Kidney Diseases; Male; Methotrexate; Middle Aged; Prostatic Neoplasms; Proteinuria; Urinary Bladder Neoplasms; Vincristine | 1993 |
[Optimal way of administration of granulocyte colony stimulating factor in the treatment of urological cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Male; Methotrexate; Middle Aged; Testicular Neoplasms; Ureteral Neoplasms; Urinary Bladder Neoplasms; Vinblastine | 1993 |
Extrapulmonary small cell carcinoma: a single-institution experience and review of the literature.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Laryngeal Neoplasms; Male; Middle Aged; Prostatic Neoplasms; Remission Induction; Retrospective Studies; Urinary Bladder Neoplasms | 1994 |
Evaluation of multiple drug resistance in human bladder cancer cell lines.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Carrier Proteins; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Etoposide; Humans; Membrane Glycoproteins; Neoplasm Proteins; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Verapamil | 1993 |
[Evaluation of the anticancer effect of cisplatin and etoposide against nude mice transplanted urological malignant tumors].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Drug Evaluation; Etoposide; Humans; Infusions, Parenteral; Kidney Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Urinary Bladder Neoplasms | 1994 |
[MEP (methotrexate, etoposide and cisplatin) and M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced uroepithelial cancer--a preliminary report of MEP as second line chemotherapy for recurrence after M-VAC].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Ureteral Neoplasms; Urinary Bladder Neoplasms; Vinblastine | 1994 |
An unusual case of haematuria.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Hematuria; Humans; Ifosfamide; Male; Mesna; Quadriplegia; Urinary Bladder Neoplasms | 1993 |
Myocardial ischemia after treatment with methotrexate, etoposide and cisplatin.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Humans; Male; Methotrexate; Middle Aged; Myocardial Ischemia; Urinary Bladder Neoplasms | 1993 |
[A case of complete response was achieved with arterial infusion chemotherapy including CDDP, etoposide and pirarubicin].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Etoposide; Humans; Infusions, Intra-Arterial; Male; Preoperative Care; Remission Induction; Urinary Bladder; Urinary Bladder Neoplasms | 1993 |
Non-P-glycoprotein-mediated atypical multidrug resistance in a human bladder cancer cell line.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Carcinoma, Transitional Cell; Cisplatin; DNA Topoisomerases, Type II; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Fluorouracil; Humans; Mitomycin; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Selection, Genetic; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Verapamil; Vinca Alkaloids | 1995 |
Hypersensitivity of human testicular tumors to etoposide-induced apoptosis is associated with functional p53 and a high Bax:Bcl-2 ratio.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Cell Line; Cell Survival; DNA Damage; DNA, Neoplasm; Dose-Response Relationship, Drug; Etoposide; Flow Cytometry; Humans; Male; Nocodazole; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Testicular Neoplasms; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Urinary Bladder Neoplasms | 1996 |
[Chemotherapy for advanced urothelial cancer patients with a combination of low-dose consecutive cisplatin and etoposide].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intravenous; Kidney Neoplasms; Male; Middle Aged; Urinary Bladder Neoplasms | 1996 |
[Efficacy of the chemosensitivity test using collagen gel matrix-supported culture system for urogenital tumors].
Topics: Animals; Antineoplastic Agents; Bleomycin; Carcinoma, Renal Cell; Cisplatin; Collagen; Culture Media; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Female; Humans; Kidney Neoplasms; Mice; Mice, Inbred C3H; Mitomycin; Urinary Bladder Neoplasms; Vinblastine | 1996 |
Mechanism of increased sensitivity to etoposide in a mitomycin C-resistant human bladder cancer cell line.
Topics: Antineoplastic Agents, Phytogenic; DNA Topoisomerases, Type II; Drug Resistance, Neoplasm; Etoposide; Humans; Mitomycin; Tumor Cells, Cultured; Tumor Stem Cell Assay; Urinary Bladder Neoplasms | 1997 |
[Neoadjuvant intra-arterial chemotherapy based on chemosensitivity tests for locally invasive bladder cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Drug Administration Schedule; Drug Screening Assays, Antitumor; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Mitomycin; Peplomycin; Prognosis; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Vinblastine | 1997 |
Extragonadal germ cell tumour involving the urinary bladder.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Male; Middle Aged; Teratoma; Urinary Bladder Neoplasms | 1997 |
Side effects of chemotherapy for advanced urothelial carcinoma with etoposide and ifosfamide.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Etoposide; Female; Humans; Ifosfamide; Kidney Neoplasms; Male; Middle Aged; Urinary Bladder Neoplasms | 1997 |
Intracellular glutathione content of urothelial cancer in correlation to chemotherapy response.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cytarabine; Drug Resistance, Neoplasm; Etoposide; Female; Glutathione; Humans; Male; Middle Aged; Mitoxantrone; Ureteral Neoplasms; Urinary Bladder Neoplasms | 1997 |
[Usefulness of magnetic resonance imaging for evaluation of therapeutic efficacy of bone metastases from bladder cancer: a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Magnetic Resonance Imaging; Male; Methotrexate; Urinary Bladder Neoplasms; Vinblastine | 1998 |
Induction of drug-resistant bladder carcinoma cells in vitro: impact on polychemotherapy with cisplatin, methotrexate and vinblastine (CMV).
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cell Cycle; Cell Division; Cisplatin; DNA, Neoplasm; Drug Resistance, Neoplasm; Etoposide; Flow Cytometry; Humans; Methotrexate; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Vinblastine | 1998 |
[A case of primary malignant lymphoma of the bladder].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisolone; Remission Induction; Urinary Bladder Neoplasms; Vincristine | 1998 |
Differential regulation of p21waf-1/cip-1 and Mdm2 by etoposide: etoposide inhibits the p53-Mdm2 autoregulatory feedback loop.
Topics: Antineoplastic Agents; Apoptosis; Bleomycin; Carcinoma, Transitional Cell; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA Damage; DNA Repair; DNA, Neoplasm; Etoposide; Feedback; Humans; Male; Nuclear Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; Testicular Neoplasms; Testis; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Urinary Bladder Neoplasms | 1999 |
[Small cell carcinoma of the urinary bladder: a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Drug Administration Schedule; Etoposide; Humans; Male; Middle Aged; Neoplasm Staging; Treatment Outcome; Urinary Bladder Neoplasms | 2000 |
F 11782, a dual inhibitor of topoisomerases I and II with an original mechanism of action in vitro, and markedly superior in vivo antitumour activity, relative to three other dual topoisomerase inhibitors, intoplicin, aclarubicin and TAS-103.
Topics: Aclarubicin; Aminoquinolines; Animals; Antineoplastic Agents; Cell Division; Enzyme Inhibitors; Etoposide; Humans; Indenes; Indoles; Leukemia L1210; Leukemia P388; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Naphthalenes; Pyrans; Pyridines; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 2000 |
Retinoblastoma protein-initiated cellular growth arrest overcomes the ability of cotransfected wild-type p53 to induce apoptosis.
Topics: Animals; Apoptosis; Cell Cycle; Cyclin-Dependent Kinase Inhibitor p16; Etoposide; Genes, p53; Genes, Retinoblastoma; Humans; Mice; Mice, Nude; Recombinant Proteins; Retinoblastoma Protein; Reverse Transcriptase Polymerase Chain Reaction; Transfection; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays | 2000 |
Advanced adenocarcinoma of the urinary bladder successfully treated by the combination of cisplatinum, mitomycin-C, etoposide and tegafur-uracil chemotherapy.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Humans; Middle Aged; Mitomycin; Neoplasm Staging; Remission Induction; Tegafur; Urinary Bladder Neoplasms | 2001 |
Combination chemotherapy with ifosfamide, 5-fluorouracil, etoposide and cisplatin for metastatic urothelial cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cisplatin; Etoposide; Female; Fluorouracil; Humans; Ifosfamide; Male; Middle Aged; Urinary Bladder Neoplasms | 2001 |
Limited penetration of anticancer drugs through tumor tissue: a potential cause of resistance of solid tumors to chemotherapy.
Topics: Animals; Antineoplastic Agents; Biological Availability; Cisplatin; Deoxycytidine; Diffusion; Drug Resistance, Neoplasm; Etoposide; Gemcitabine; Humans; Mammary Neoplasms, Experimental; Membranes, Artificial; Mice; Neoplasm Staging; Paclitaxel; Polytetrafluoroethylene; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Vinblastine | 2002 |
[Intra-arterial infusion chemotherapy of advanced bladder cancer].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cisplatin; Drug Administration Schedule; Epirubicin; Etoposide; Female; Humans; Infusions, Intra-Arterial; Male; Prognosis; Urinary Bladder Neoplasms | 1992 |
[MEC treatment (methotrexate, etoposide, cisplatin) for urothelial cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Kidney Neoplasms; Male; Methotrexate; Middle Aged; Urinary Bladder Neoplasms | 1992 |
[Combined treatment of invasive bladder cancer by intra-arterial infusion chemotherapy of cisplatin with or without other anticancer agents and concurrent radiotherapy--initial response and side effects].
Topics: Aged; Aged, 80 and over; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Humans; Iliac Artery; Infusions, Intravenous; Japan; Male; Methotrexate; Middle Aged; Retrospective Studies; Urinary Bladder Neoplasms | 1992 |
Relationship between topoisomerase II level and chemosensitivity in human tumor cell lines.
Topics: Amsacrine; Blotting, Western; Cell Death; Cross-Linking Reagents; DNA Damage; DNA Topoisomerases, Type II; Doxorubicin; Etoposide; Humans; In Vitro Techniques; Male; Testicular Neoplasms; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1991 |
Treatment of bladder carcinoma using a germ cell chemotherapy protocol.
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Carcinoembryonic Antigen; Carcinoma, Transitional Cell; Chorionic Gonadotropin; Cisplatin; Etoposide; Humans; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Urinary Bladder Neoplasms; Vincristine | 1990 |
Multi-drug resistance of a doxorubicin-resistant bladder cancer cell line.
Topics: Bleomycin; Cell Survival; Doxorubicin; Drug Resistance; Etoposide; Humans; Tumor Cells, Cultured; Tumor Stem Cell Assay; Urinary Bladder Neoplasms; Vinblastine | 1990 |
Effect of verapamil on the uptake and efflux of etoposide (VP16) in both sensitive and resistant cancer cells.
Topics: Animals; Carcinoma, Transitional Cell; Culture Media; Drug Resistance; Etoposide; Glucose; Humans; Kinetics; Leukemia L1210; Mice; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Verapamil | 1991 |
[The activity of etoposide (VP16) in combination chemotherapy against human bladder cancer cells in vitro].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; Etoposide; Humans; Methotrexate; Tumor Cells, Cultured; Tumor Stem Cell Assay; Urinary Bladder Neoplasms; Vinblastine | 1991 |
[Intra-arterial infusion chemotherapy for advanced bladder cancer and prostate cancer using reservoir system].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Epirubicin; Etoposide; Female; Humans; Infusion Pumps; Infusions, Intra-Arterial; Male; Middle Aged; Prognosis; Prostatic Neoplasms; Urinary Bladder Neoplasms | 1991 |
[Combination chemotherapy of methotrexate, etoposide, adriamycin and cisplatin (M-EAP) for advanced urothelial cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Male; Methotrexate; Middle Aged; Prognosis; Ureteral Neoplasms; Urinary Bladder Neoplasms | 1991 |
[Complete remission of bone metastasis of bladder cancer treated by cisplatin-etoposide therapy].
Topics: Acetabulum; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Combined Modality Therapy; Cystectomy; Drug Administration Schedule; Etoposide; Humans; Male; Remission Induction; Urinary Bladder Neoplasms | 1991 |
[Effect of etoposide orally administered every other day for the prevention of recurrence of bladder tumor].
Topics: Administration, Intravesical; Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Postoperative Period; Urinary Bladder Neoplasms | 1990 |
The inhibition of cellular recovery in human tumour cells by inhibitors of topoisomerase.
Topics: Camptothecin; Cell Survival; DNA; DNA Repair; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Drug Combinations; Etoposide; Humans; Radiation Tolerance; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Urinary Bladder Neoplasms | 1990 |
[Plasma methotrexate concentrations in urothelial cancer chemotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Kidney Neoplasms; Kidney Pelvis; Male; Methotrexate; Middle Aged; Urinary Bladder Neoplasms | 1990 |
[Clinical evaluation of chemotherapy in urologic cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Staging; Penile Neoplasms; Prognosis; Remission Induction; Testicular Neoplasms; Urinary Bladder Neoplasms; Urogenital Neoplasms; Vinblastine | 1989 |
Successful management of small cell carcinoma of the bladder with cisplatin and etoposide.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Humans; Male; Middle Aged; Urinary Bladder Neoplasms | 1989 |
Immunochemotherapy for murine bladder tumor with a new human recombinant tumor necrosis factor (rTNF-S), VP-16 and hyperthermia.
Topics: Animals; Carcinoma, Transitional Cell; Combined Modality Therapy; Etoposide; Female; Humans; Hyperthermia, Induced; Immunotherapy; Mice; Mice, Inbred C3H; Recombinant Proteins; Species Specificity; Tumor Necrosis Factor-alpha; Urinary Bladder Neoplasms | 1989 |
Recombinant human tumor necrosis factor alone and with chemotherapeutic agents. Effect on nude mouse-supported human bladder cancer heterografts.
Topics: Animals; Antineoplastic Agents; Carcinoma, Transitional Cell; Cell Line; Cisplatin; Dactinomycin; Doxorubicin; Drug Synergism; Drug Therapy, Combination; Etoposide; Mice; Mice, Nude; Neoplasm Transplantation; Recombinant Proteins; Subrenal Capsule Assay; Tumor Necrosis Factor-alpha; Urinary Bladder Neoplasms | 1989 |
Tumor necrosis factor enhances the in vitro and in vivo efficacy of chemotherapeutic drugs targeted at DNA topoisomerase II in the treatment of murine bladder cancer.
Topics: Animals; Antineoplastic Agents; Dactinomycin; DNA Topoisomerases, Type II; Doxorubicin; Etoposide; Female; Glycoproteins; Macrophage Activation; Mice; Recombinant Proteins; Teniposide; Tumor Necrosis Factor-alpha; Urinary Bladder Neoplasms | 1987 |
[Phase II study of etoposide (VP-16-213) in genitourinary tumors. VP-16-213 Genitourinary Study Group].
Topics: Adult; Aged; Alopecia; Anorexia; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Male; Middle Aged; Nausea; Podophyllotoxin; Prostatic Neoplasms; Testicular Neoplasms; Urinary Bladder Neoplasms; Urogenital Neoplasms | 1986 |
Phase II study of etoposide for carcinoma of the bladder: the Southeastern Cancer Study Group experience.
Topics: Drug Evaluation; Etoposide; Humans; Urinary Bladder Neoplasms | 1986 |
Chemotherapy of invasive carcinoma of the bladder.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Etoposide; Humans; Lymphatic Metastasis; Methotrexate; Neoplasm Invasiveness; Urinary Bladder Neoplasms | 1985 |
[Effect of etoposide for urogenital tumors].
Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Aged; Antineoplastic Agents, Phytogenic; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Parenteral; Male; Middle Aged; Pancreatic Neoplasms; Podophyllotoxin; Prostatic Neoplasms; Rhabdomyosarcoma; Ureteral Neoplasms; Urinary Bladder Neoplasms; Urogenital Neoplasms | 1985 |